Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central... see more

TSX:HLS - Post Discussion

HLS Therapeutics Inc > BC Drug Plan
View:
Post by screamer99 on Feb 06, 2024 12:24pm

BC Drug Plan

Discussion boards are dead everywhere I can see, but the reimbursement from BC is big news.

Last March, when it was announced that discussions were ongoing, this stock fell from $8 to where it is now.

I would think the Alberta reimbursement will follow at some point this year.

Earnings may be flat for the next couple of quarters, but can't help but think this thing will be a few dollars higher by next summer.

Time will tell.
Comment by screamer99 on Jul 29, 2024 8:13pm
Now we know what that 400k+ (hitting the ask) trade was about last Wednesday.  Took a little longer than expected for the AB Drug Plan, but now we're here. Will take several quarters for the market to get excited about this but whenever the amortization drops off (haven't bothered to look) and we can show positive EPS, the ride will start.  Until then, reasonable cash flows ...more